| Filed On | Filing |
|---|---|
| 22 Sep 2026 |
Form 4: Coll Crespo Blas, CHIEF MEDICAL OFFICER
Gave up 10,626 shares to cover exercise price or tax ($124K) · Disposed of 12,024 shares (Derivative Conversion) · Acquired 4,008 American Depositary Shares (Derivative Conversion) · 1 more |
| 02 Sep 2026 |
Form 4: Lin Xichen, CHIEF SCIENTIFIC OFFICER
Received 17,817 shares by exercise or conversion ($6.06K) · Disposed of 17,817 shares (Derivative Conversion) · Acquired 5,939 American Depositary Shares (Derivative Conversion) · 1 more |
| 19 Aug 2026 |
Form 4: Lin Xichen, CHIEF SCIENTIFIC OFFICER
Received 11,817 shares by exercise or conversion ($4.02K) · Disposed of 11,817 shares (Derivative Conversion) · Acquired 3,939 American Depositary Shares (Derivative Conversion) · 1 more |
| 07 Aug 2026 |
Form 4: Berrios John Joseph, Chief Commercial Officer
Received 140,766 shares as a grant or award · Granted 174,612 Share option (right to buy) |
| 05 Aug 2026 |
Form 4: Lin Xichen, CHIEF SCIENTIFIC OFFICER
Received 11,817 shares by exercise or conversion ($4.02K) · Disposed of 11,817 shares (Derivative Conversion) · Acquired 3,939 American Depositary Shares (Derivative Conversion) · 1 more |
| 24 Jul 2026 |
Form 4: Fmr Llc, 10% owner
Disposed of 17,452 American Depositary Shares (Open Market Sale) ($874K) |
| 15 Jul 2026 |
Form 4: Lin Xichen, CHIEF SCIENTIFIC OFFICER
Received 23,634 shares by exercise or conversion ($8.04K) · Disposed of 23,634 shares (Derivative Conversion) · Acquired 7,878 American Depositary Shares (Derivative Conversion) · 1 more |
| 29 Jun 2026 |
Form 4: Lin Xichen, CHIEF SCIENTIFIC OFFICER
Received 23,634 shares by exercise or conversion ($8.04K) · Disposed of 23,634 shares (Derivative Conversion) · Acquired 7,878 American Depositary Shares (Derivative Conversion) · 1 more |
| 18 Jun 2026 |
Form 4: Russell Angus C., Director
Granted 39,453 Share Option (right to buy) |
| 18 Jun 2026 |
Form 4: Love Ted W, Director
Granted 39,453 Share Option (right to buy) |
| 18 Jun 2026 |
Form 4: Waldstreicher Joanne, Director
Granted 39,453 Share Option (right to buy) |
| 18 Jun 2026 |
Form 4: Dobmeier Eric, Director
Granted 39,453 Share Option (right to buy) |
| 18 Jun 2026 |
Form 4: Tetlow Sharon, Director
Granted 39,453 Share Option (right to buy) |
| 18 Jun 2026 |
Form 4: Welch Daniel G, Director
Granted 39,453 Share Option (right to buy) |
| 23 Apr 2026 |
Form 4: Lang Matthew, COO & GC
Received 184,614 shares as a grant or award · Granted 223,776 Share option (right to buy) |
| 16 Apr 2026 |
Form 4: Fmr Llc, 10% owner
Disposed of 17,452 American Depositary Shares (Open Market Sale) ($961K) |
| 23 Mar 2026 |
Form 4: Hall Ashley, Chief Development Officer
Received 47,706 shares as a grant or award · Granted 59,073 Employee Stock Option (right to buy) |
| 23 Mar 2026 |
Form 4: Coll Crespo Blas, CHIEF MEDICAL OFFICER
Received 75,897 shares as a grant or award · Granted 93,984 Employee Stock Option (right to buy) |
| 23 Mar 2026 |
Form 4: Ma Yingli, CHIEF TECHNOLOGY OFFICER
Received 32,526 shares as a grant or award · Granted 40,278 Employee Stock Option (right to buy) |
| 23 Mar 2026 |
Form 4: Lin Xichen, CHIEF SCIENTIFIC OFFICER
Received 43,368 shares as a grant or award · Granted 53,703 Employee Stock Option (right to buy) |
Loading...